BioGaia AB (publ) (STO: BIOG.B)
Sweden
· Delayed Price · Currency is SEK 109.60
+0.30 (0.27%)
Oct 4, 2024, 5:29 PM CET
BioGaia AB Revenue
BioGaia AB had revenue of 384.12M SEK in the quarter ending June 30, 2024, with 21.86% growth. This brings the company's revenue in the last twelve months to 1.37B, up 12.89% year-over-year. In the year 2023, BioGaia AB had annual revenue of 1.30B with 17.44% growth.
Revenue (ttm)
1.37B
Revenue Growth
+12.89%
P/S Ratio
8.08
Revenue / Employee
6.22M
Employees
210
Market Cap
11.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
| Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
| Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
| Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
| Dec 31, 2019 | 768.35M | 26.48M | 3.57% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 520.76B |
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.17B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |